Thoracic surgical interventions for DR-TB and their results
Background: Surgery in DR-TB is a highly contested intervention. However, in suitable selected cases, it has a great role in improving outcomes of treatment as well as symptomatic improvement in the quality of life of the patient. Indications of surgery in this setting will be localized disease with...
| Published in: | International Journal of Mycobacteriology |
|---|---|
| Main Author: | Ravindra Kumar Dewan |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
| Subjects: | |
| Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=55;epage=55;aulast=Dewan |
Similar Items
Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01)
by: K. Bennani, et al.
Published: (2024-09-01)
Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South Africa
by: Ndiviwe Mphothulo, et al.
Published: (2025-01-01)
by: Ndiviwe Mphothulo, et al.
Published: (2025-01-01)
Predictors of drug-resistant TB outcomes: Body mass index, HIV, and comorbidities
by: Ntandazo Dlatu, et al.
Published: (2025-10-01)
by: Ntandazo Dlatu, et al.
Published: (2025-10-01)
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 months
by: Nitin Jain, et al.
Published: (2025-03-01)
by: Nitin Jain, et al.
Published: (2025-03-01)
Information counselling during treatment with ototoxic medications for TB: a call to action
by: K. Khoza-Shangase, et al.
Published: (2025-03-01)
by: K. Khoza-Shangase, et al.
Published: (2025-03-01)
A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
by: M.L. Rekart, et al.
Published: (2024-07-01)
by: M.L. Rekart, et al.
Published: (2024-07-01)
Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)
by: R. Crowder, et al.
Published: (2024-10-01)
Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)
by: Sara Occhineri, et al.
Published: (2022-01-01)
Observations as a doctor in a TB hospital
by: Sigrid A. Schulz
Published: (2007-06-01)
by: Sigrid A. Schulz
Published: (2007-06-01)
The TB REACH Initiative: Supporting TB Elimination Efforts in the Asia-Pacific
by: Jacob Creswell, et al.
Published: (2020-10-01)
by: Jacob Creswell, et al.
Published: (2020-10-01)
The risk of rifampicin-resistant TB after drug-susceptible TB treatment
by: A.N. Shapiro, et al.
Published: (2025-03-01)
by: A.N. Shapiro, et al.
Published: (2025-03-01)
Rifampin Resistant Tuberculosis; Factors and Demo- Graphic Features
by: Huda Sarwar, et al.
Published: (2024-09-01)
by: Huda Sarwar, et al.
Published: (2024-09-01)
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries
by: N. Suryavanshi, et al.
Published: (2025-10-01)
by: N. Suryavanshi, et al.
Published: (2025-10-01)
Migration, TB control and elimination: Whom to screen and treat☆
by: A. Rendon, et al.
Published: (2018-03-01)
by: A. Rendon, et al.
Published: (2018-03-01)
Data-driven targets for reducing the global burden of TB
by: C.R. Horsburgh Jr., et al.
Published: (2025-06-01)
by: C.R. Horsburgh Jr., et al.
Published: (2025-06-01)
TB yields from expanded contact tracing investigations
by: A. Madan, et al.
Published: (2025-03-01)
by: A. Madan, et al.
Published: (2025-03-01)
Temporal pattern and effect of COVID-19 on the trend of TB, DRTB, paediatrics TB and TB with HIV Coinfection: A decadal trend analysis
by: Pushpendra Bairwa, et al.
Published: (2024-12-01)
by: Pushpendra Bairwa, et al.
Published: (2024-12-01)
Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm
by: Mojisola Clara Hosu, et al.
Published: (2024-10-01)
by: Mojisola Clara Hosu, et al.
Published: (2024-10-01)
Incidence and risk factors of myelosuppression of linezolid in patients with drug-resistant tuberculosis: A scoping review
by: Oki Nugraha Putra, et al.
Published: (2024-01-01)
by: Oki Nugraha Putra, et al.
Published: (2024-01-01)
Effect of delamanid on interim outcomes of bacteriological conversion amongst pediatric drug resistant tuberculosis cases in India
by: Dhruv Kalawadia, et al.
Published: (2024-01-01)
by: Dhruv Kalawadia, et al.
Published: (2024-01-01)
Treatment Outcomes and Associated Factors among Tuberculosis Patients from Selected Rural Eastern Cape Hospitals: An Ambidirectional Study
by: Lindiwe M. Faye, et al.
Published: (2023-06-01)
by: Lindiwe M. Faye, et al.
Published: (2023-06-01)
Determinants of TB/HIV coinfection-related deaths audited using the TB death checklist from health facilities in Rwanda
by: Mutembayire et al.
Published: (2025-03-01)
by: Mutembayire et al.
Published: (2025-03-01)
The Effect of Health Education with TB Card on The Prevention of Pulmonary TB Transmission Behavior
by: Pipit Festi Wiliyanarti, et al.
Published: (2020-07-01)
by: Pipit Festi Wiliyanarti, et al.
Published: (2020-07-01)
15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB
by: M.J. Nasiri, et al.
Published: (2025-04-01)
by: M.J. Nasiri, et al.
Published: (2025-04-01)
TINGKAT PENGETAHUAN TENTANG TB PARU MEMPENGARUHI PENGGUNAAN MASKER DI RUANG PARU RUMKITAL Dr. RAMELAN SURABAYA
by: Nur Wachida Novita, et al.
Published: (2018-04-01)
by: Nur Wachida Novita, et al.
Published: (2018-04-01)
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
by: M. van den Boom, et al.
Published: (2024-01-01)
by: M. van den Boom, et al.
Published: (2024-01-01)
Risk factors for negative T-SPOT.TB assay results in patients with confirmed active tuberculosis: A retrospective study
by: Yanwan Shangguan, et al.
Published: (2020-11-01)
by: Yanwan Shangguan, et al.
Published: (2020-11-01)
The prevalence and socio-demographic characteristics of persons with TB and TB/HIV co-infection at the chest clinic of the University of Nigeria teaching hospital, Enugu, Nigeria
by: O C Ekwueme, et al.
Published: (2009-01-01)
by: O C Ekwueme, et al.
Published: (2009-01-01)
Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)
by: A.K. McDonald, et al.
Published: (2024-12-01)
Drug-Resistant TB, HIV and COVID-19 Co-Infection: Case Reviews from Kwa-Zulu Natal, South Africa
by: Hassan-Moosa R, et al.
Published: (2023-12-01)
by: Hassan-Moosa R, et al.
Published: (2023-12-01)
TB death surveillance and response (TBDSR) - A step towards zero deaths due to TB. Lessons learnt from West Bengal, India
by: Abhijit Dey, et al.
Published: (2025-07-01)
by: Abhijit Dey, et al.
Published: (2025-07-01)
A child with confirmed pulmonary TB with suspected extra-pulmonary TB manifestation: Role of family physician in prompt diagnosis and management
by: Teja S. R. Krishna, et al.
Published: (2025-03-01)
by: Teja S. R. Krishna, et al.
Published: (2025-03-01)
The Definitive Diagnosis of Tuberculous Meningitis (TBM) di RSUP dr. Kariadi Semarang Descriptive study in adult patients using IS6110-based PCR amplification for detecting Mycobacterium tuberculosis
by: Masfiyah Masfiyah, et al.
Published: (2013-12-01)
by: Masfiyah Masfiyah, et al.
Published: (2013-12-01)
Drug resistant TB – latest developments in epidemiology, diagnostics and management
by: Simon Tiberi, et al.
Published: (2022-11-01)
by: Simon Tiberi, et al.
Published: (2022-11-01)
STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS
by: Rinto Susilo, et al.
Published: (2025-06-01)
by: Rinto Susilo, et al.
Published: (2025-06-01)
Update of drug-resistant tuberculosis treatment guidelines: A turning point
by: Elisa Vanino, et al.
Published: (2023-05-01)
by: Elisa Vanino, et al.
Published: (2023-05-01)
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea
by: F. Charles, et al.
Published: (2024-09-01)
by: F. Charles, et al.
Published: (2024-09-01)
Effect of TB Treatment on Neutrophil-Derived Soluble Inflammatory Mediators in TB Patients with and without HIV Coinfection
by: Nádia Sitoe, et al.
Published: (2023-06-01)
by: Nádia Sitoe, et al.
Published: (2023-06-01)
Assessing the impact of the TB response in Taiwan – the journey towards ending TB
by: P.-C. Chan, et al.
Published: (2025-05-01)
by: P.-C. Chan, et al.
Published: (2025-05-01)
Community based peer-led TB screening intervention: an innovative approach to increase TB knowledge, presumptive case identification, and referral among sexual minority people in urban Bangladesh
by: Golam Sarwar, et al.
Published: (2023-07-01)
by: Golam Sarwar, et al.
Published: (2023-07-01)
Similar Items
-
Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01) -
Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South Africa
by: Ndiviwe Mphothulo, et al.
Published: (2025-01-01) -
Predictors of drug-resistant TB outcomes: Body mass index, HIV, and comorbidities
by: Ntandazo Dlatu, et al.
Published: (2025-10-01) -
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 months
by: Nitin Jain, et al.
Published: (2025-03-01) -
Information counselling during treatment with ototoxic medications for TB: a call to action
by: K. Khoza-Shangase, et al.
Published: (2025-03-01)
